Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone reflects skepticism about the effectiveness of MB and MitoQ in slowing skeletal aging, exemplified by posts stating that these treatments 'do not have any effect,' and comments that emphasize the need for more comprehensive approaches. The use of phrases like 'do not significantly prevent' and references to the limited impact demonstrate cautious interpretation and restrained optimism from the community.
Most discussions highlight that the antioxidants MB and MitoQ did not significantly influence skeletal aging, indicating a cautious or skeptical stance.
There is a moderate level of interest, with many posts sharing the publication and commenting on its findings, though some posts quickly dismiss the impact.
Several posts delve into the methodology and implications, showing an active engagement, although some merely share or acknowledge the publication.
The majority believe the findings suggest limited effects of these antioxidants on aging, implying the results may not lead to immediate breakthroughs.
MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging @SchafflerLab @ShoshanaYakar https://t.co/UUJAYGM8Xi https://t.co/ViRjLWON1m
Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging https://t.co/r4bDSTomuz #bioRxiv
Listen to an #audio version of a #pressrelease on the #researchpaper, "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging." https://t.co/4tyK6UkHLq #aging #openaccess #podcast #soundcloud #publishing #press #research
#PaperoftheDay: "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging" DOI: https://t.co/QCuaBqtNiF #aging #openaccess #openscience #peerreviewed #meded
#PressRelease: On March 25, @NYUDental @CUNY @jacksonlab @umich @texvet & @uthealthhouston researchers published a new research paper in Aging, entitled, “Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging.” https://t.co/Me2eHMjMBi
AgingUS discusses research on targeting mitochondrial dysfunction with methylene blue and mitoquinone to improve skeletal aging. The study shows that long-term antioxidant treatment alone may not prevent age-related…
Methylene Blue has been promoted as a potential anti-aging supplement and treatment for neurodegenerative and cardiovascular diseases. This video discusses its effects on mitochondrial function, health benefits, and…
Aging-US recently #published this #trendingwithimpact research #paper in Volume 16, Issue 6, entitled, “Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging." @NYUDental https://t.co/QCuaBqtNiF #aging #research #oa #agingshort #video https://t.co/pN01SIXjoy
Aging-US recently #published this #trendingwithimpact research #paper in Volume 16, Issue 6, entitled, “Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging." @NYUDental https://t.co/QCuaBqul8d #aging #research #oa #agingshort #video https://t.co/ZtKURRx7bs
#PaperoftheDay: "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging" DOI: https://t.co/QCuaBqtNiF #aging #openaccess #openscience #peerreviewed #meded
Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging https://t.co/lrpyywqnLg
RT @Madam_Mito: MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
RT @Madam_Mito: MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
RT @AgingJrnl: Listen to an #audio version of a #pressrelease on the #researchpaper, "Targeting mitochondrial dysfunction using methylene b…
RT @Madam_Mito: MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
RT @Madam_Mito: MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
RT @Madam_Mito: MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
RT @AgingJrnl: #PressRelease: On March 25, @NYUDental @CUNY @jacksonlab @umich @texvet & @uthealthhouston researchers published a new resea…
RT @Madam_Mito: MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
RT @AgingJrnl: Listen to an #audio version of a #pressrelease on the #researchpaper, "Targeting mitochondrial dysfunction using methylene b…
RT @AgingJrnl: #TrendingWithImpact: On March 25, @NYUDental @CUNY @jacksonlab @umich @texvet & @uthealthhouston researchers published a new…
RT @Madam_Mito: MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
RT @AgingJrnl: Listen to an #audio version of a #pressrelease on the #researchpaper, "Targeting mitochondrial dysfunction using methylene b…
RT @Madam_Mito: MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
RT @AgingJrnl: #PressRelease: On March 25, @NYUDental @CUNY @jacksonlab @umich @texvet & @uthealthhouston researchers published a new resea…
RT @AgingJrnl: #TrendingWithImpact: On March 25, @NYUDental @CUNY @jacksonlab @umich @texvet & @uthealthhouston researchers published a new…
RT @Madam_Mito: MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
MB or MitoQ do not have any effect on the pace of aging https://t.co/4cEBhFTUAv
#TrendingWithImpact: On March 25, @NYUDental @CUNY @jacksonlab @umich @texvet & @uthealthhouston researchers published a new research paper in Aging: “Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging” DOI: https://t.co/QCuaBqtNiF https://t.co/YA6JL2Mzr5
Listen to an #audio version of a #pressrelease on the #researchpaper, "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging." https://t.co/4tyK6UkHLq #aging #openaccess #podcast #soundcloud #publishing #press #research
Aging-US recently #published this #trendingwithimpact research #paper in Volume 16, Issue 6, entitled, “Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging." @NYUDental https://t.co/QCuaBqtNiF #aging #research #oa #agingshort #video https://t.co/XOijfTQ35K
RT @AgingJrnl: #PressRelease: On March 25, @NYUDental @CUNY @jacksonlab @umich @texvet & @uthealthhouston researchers published a new resea…
#PressRelease: On March 25, @NYUDental @CUNY @jacksonlab @umich @texvet & @uthealthhouston researchers published a new research paper in Aging, entitled, “Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging.” https://t.co/Me2eHMjMBi
RT @AgingJrnl: #PaperoftheDay: "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging" DOI: ht…
RT @agingdoc1: Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging @SchafflerLab @ShoshanaYa…
RT @agingdoc1: Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging @SchafflerLab @ShoshanaYa…
RT @agingdoc1: Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging @SchafflerLab @ShoshanaYa…
RT @agingdoc1: Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging @SchafflerLab @ShoshanaYa…
RT @agingdoc1: Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging @SchafflerLab @ShoshanaYa…
Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging @SchafflerLab @ShoshanaYakar https://t.co/UUJAYGM8Xi https://t.co/ViRjLWON1m
RT @AgingJrnl: #PaperoftheDay: "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging" DOI: ht…
RT @AgingJrnl: #PaperoftheDay: "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging" DOI: ht…
RT @AgingJrnl: #PaperoftheDay: "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging" DOI: ht…
RT @AgingJrnl: #PaperoftheDay: "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging" DOI: ht…
#PaperoftheDay: "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging" DOI: https://t.co/QCuaBqtNiF #aging #openaccess #openscience #peerreviewed #meded
Long-term administration of methylene blue (MB) and Mitoquinone (MitoQ) did not halt age-induced bone loss in mice, suggesting antioxidants alone may not suffice to prevent skeletal aging.
RT @biorxivpreprint: Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging https://t.co/r4bDST…
RT @biorxivpreprint: Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging https://t.co/r4bDST…
Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging https://t.co/r4bDSTomuz #bioRxiv
... Aging, s ... 10.18632/aging.205147 Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging.
... aging.” Read the full paper: DOI: https://doi.org/10.18632/aging.205147. Corresponding Author: Shoshana Yakar. Corresponding Email: sy1007@nyu ...
... aging does not alter trabecular bone morphology of the axial skeleton. Credit: Aging (2024). DOI: 10.18632/aging.205147. A new research paper ...
Permalink: https://doi.org/10.18632/aging.205147. I am a bot, and this action was performed automatically. Please contact the moderators of ...
Haga clic aquí para aplicar. Usuario: u/AgingUS. Enlace permanente: https://doi.org/10.18632/aging.205147. Soy un bot, y esta acción se ...
MM
A
B
AU
AP
F
CV
MM
A
JB
TM
GL
YX
M
DF
IL
JG
SP
DD
MS
LV
S
DJ
LG
TS
AK
T